Search for: "Drake v. Davis" Results 21 - 39 of 39
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jul 2019, 10:00 am by sydniemery
Justice Gorsuch penned the majority opinion, available here: https://casetext.com/case/united-states-v-davis-2053. 8. [read post]
9 Aug 2012, 5:00 am by Bexis
(biliary stent) Deposition1999-08-20 Drake v. [read post]
21 Dec 2009, 3:06 am
Hamilton (Drake), Gregg W. [read post]
21 Nov 2019, 6:03 am by Derek T. Muller
of Texas at Austin 1.18 $106,598 $90,100 V&erbilt Univ. 1.19 $129,030 $108,800 Univ. of Arkansas 1.19 $61,500 $51,700 Mitchell Hamline Sch. of Law 1.21 $64,429 $53,200 Univ. of California-Los Angeles 1.26 $121,453 $96,600 Univ. of North Dakota 1.26 $61,500 $48,800 Univ. of Kansas 1.27 $66,415 $52,100 Univ. of Kentucky 1.28 $69,860 $54,400 Univ. of Mississippi 1.32 $64,300 $48,700 The Univ. [read post]
29 Dec 2017, 7:34 am by Ben
In the UK in FAPL v BT [2017] Mr Justice Arnold concluded that the High Court has the jurisdiction to make an order against an access provider that would require the ISP to block access not to a website but rather streaming servers giving unauthorised access to copyright content - 'live' blocking. [read post]
8 Jun 2018, 12:30 pm by Dan Ernst
  THURSDAY The Rights Revolution in Action: The Transformation of State Institutions after the 1960sThu, 6/7: 8:00 AM—9:45 AM, Sheraton Centre Toronto, Forest Hill ·         Chair/Discussant—Sara Mayeux, Vanderbilt University ·         Ingraham v. [read post]
20 Dec 2007, 7:47 am
Title V/CSHCN has supported care notebooks for families and hired parent advocates around the state. [read post]
28 Jul 2008, 5:45 pm
A recent study estimated the annual cost of E. coli O157:H7 illnesses to be $405 million (in 2003 dollars) which included $370 million for premature deaths, $30 million for medical care, and $5 million for lost productivity (Frenzen, Drake, and Angulo, 2005). [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]